Security key
729139105
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)
CUSIP: 729139105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 64,754,179
- Total 13F value
- $852,599,671
- Share change
- +1,527,488
- Put/Call ratio
- 852%
- SEC-reported price per share
- $13.17
- Number of holders
- 158
- Value change
- +$21,507,892
- Number of buys
- 70
- Number of sells
- 56
- Shares outstanding
- 61,907,011
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
158
Top holders
10
PLRX full security history
Ownership snapshot
Full 13F holder table
PLIANT THERAPEUTICS, INC. SEC filings
PLIANT THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Deep Track Capital, LP
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
Lead comparable stake: 4.8%
13D/G row: Redmile Group, LLC
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
4.8%
Deep Track Capital, LP
9.6%
BlackRock, Inc.
8.4%
PRICE T ROWE ASSOCIATES INC /MD/
7.8%
FMR LLC
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
13D/G
Company
|
4.8%
from 13D/G
|
$35,843,874
3,197,491 shares
|
— | 30 Sep 2024 |
| Deep Track Capital, LP |
13F
Company
|
9.6%
|
$66,949,001
5,972,257 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
8.4%
|
$58,504,597
5,218,965 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
7.8%
|
$54,200,000
4,834,813 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
6.3%
|
$43,713,185
3,899,481 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
5.7%
|
$39,532,223
3,526,514 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
158
Shares
64,754,179
Rows available
158
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
149
Q4 2024 holders
158
Holder diff
9
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|